- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for 3SBio Inc (SSRX)
| Open: | 16.7000 | Day's Range: | 16.5010 - 16.7000 | Volume: | 241,399 |
|---|---|---|---|---|---|
| Previous Close: | 16.5800 | 52wk Range: | 10.1500 - 16.7000 | 1-Yr Rtn: | +20.44% |
Key Statistics for SSRX
| Current P/E Ratio (ttm) | 20.7000 |
|---|---|
| Estimated P/E(12/2013) | 17.2860 |
| Relative P/E vs. SPX | 1.2695 |
| Earnings Per Share (USD) (ttm) | 0.8000 |
| Est. EPS (USD) (12/2013) | 0.9580 |
| Est. PEG Ratio | 0.8271 |
| Market Cap (M USD) | 390.50 |
| Shares Outstanding (M) | 23.58 |
| 30 Day Average Volume | 187,021 |
| Price/Book (mrq) | 1.6660 |
| Price/Sale (ttm) | 3.4378 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SSRX
Company Profile & Key Executives for SSRX
3SBio, Inc. is a biotechnology company. The Company researches treatments in the areas of nephrology, oncology, supportive cancer care, inflammation, and infectious diseases.
| Lou JingChairman/CEO/Co-Founder | Bo TanChief Financial Officer |
| Dongmei SuVP:R&D/CTO | Bin HuangVP:Human Resources |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SSRX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page